Replies to post #224755 on Biotech Values

[biocqr]

ARWR > clinical trial listing for ARO-HBV + 2 previously undisclosed drugs...JNJ-6379 + NA

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection (REEF-1)
https://clinicaltrials.gov/ct2/show/NCT03982186

JNJ-56136379 at EASL (e472 & e473)...
https://ilc-congress.eu/wp-content/uploads/2019/04/EASL-ILC2019-AbstractBook-13042019-Final.pdf

FRI-188
Sequence analysis of baseline and on-treatment samples from
HBV-infected chronic hepatitis B patients treated for 28 days with
JNJ-56136379 monotherapy

FRI-189
HBcrAg decline in JNJ-56136379-treated chronic hepatitis B
patients: Results of a phase 1 study

ARWR Presentation...

The Science of HBV Cure 2019
http://ir.arrowheadpharma.com/static-files/d6073d43-ba9d-4f8e-b68e-9ba990e59375